PING AN HEALTHCARE AND TECHNOLOGY COMPANY LIMITED Financials Ping An Healthcare and Technology Company Limited OTC Markets
Equities
PIAHY
US72341W1062
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.66 USD | -44.23% |
|
-.--% | -44.23% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 54,224 | 90,769 | 26,143 | 21,047 | 18,060 | 12,549 | - | - |
| Enterprise Value (EV) 1 | 48,779 | 80,952 | 23,078 | 17,346 | 18,060 | 10,154 | 9,915 | 9,466 |
| P/E ratio | -69.6 x | -86 x | -16.6 x | -33.6 x | -53.8 x | -57.8 x | -1,947 x | 205 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 10.7 x | 13.2 x | 3.56 x | 3.42 x | 3.86 x | 2.27 x | 1.95 x | 1.89 x |
| EV / Revenue | 9.63 x | 11.8 x | 3.15 x | 2.82 x | 3.86 x | 1.83 x | 1.54 x | 1.42 x |
| EV / EBITDA | -59.9 x | -108 x | -16.1 x | -31.9 x | -40.2 x | -30.3 x | -77.4 x | 166 x |
| EV / FCF | -76.5 x | -68.9 x | -15.5 x | -20.5 x | - | -38.8 x | 354 x | 44.6 x |
| FCF Yield | -1.31% | -1.45% | -6.47% | -4.87% | - | -2.58% | 0.28% | 2.24% |
| Price to Book | 5.62 x | 5.73 x | 1.88 x | 1.56 x | - | 0.96 x | 0.97 x | 0.93 x |
| Nbr of stocks (in thousands) | 10,67,294 | 11,47,294 | 11,31,742 | 11,18,813 | 11,18,813 | 11,18,813 | - | - |
| Reference price 2 | 50.81 | 79.12 | 23.10 | 18.81 | 16.14 | 11.22 | 11.22 | 11.22 |
| Announcement Date | 11/02/20 | 02/02/21 | 15/03/22 | 13/03/23 | 19/03/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 5,065 | 6,866 | 7,334 | 6,160 | 4,674 | 5,538 | 6,430 | 6,654 |
| EBITDA 1 | -813.7 | -749.4 | -1,437 | -544 | -449.4 | -335.4 | -128.2 | 57.03 |
| EBIT 1 | -959.4 | -919.1 | -1,643 | -697.8 | -575.3 | -382.2 | -188 | 48.27 |
| Operating Margin | -18.94% | -13.39% | -22.41% | -11.33% | -12.31% | -6.9% | -2.92% | 0.73% |
| Earnings before Tax (EBT) 1 | -734.1 | -941.3 | -1,524 | -607.7 | -331.9 | -240.9 | -23.34 | 169.3 |
| Net income 1 | -733.9 | -948.5 | -1,538 | -607.6 | -322.6 | -212 | -0.0773 | 92.86 |
| Net margin | -14.49% | -13.81% | -20.97% | -9.86% | -6.9% | -3.83% | -0% | 1.4% |
| EPS 2 | -0.7300 | -0.9200 | -1.390 | -0.5600 | -0.3000 | -0.1941 | -0.005760 | 0.0547 |
| Free Cash Flow 1 | -637.2 | -1,175 | -1,492 | -845.1 | - | -261.7 | 28 | 212.3 |
| FCF margin | -12.58% | -17.12% | -20.35% | -13.72% | - | -4.72% | 0.44% | 3.19% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | 372.29% |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | 228.67% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 11/02/20 | 02/02/21 | 15/03/22 | 13/03/23 | 19/03/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 2,747 | 4,119 | 3,818 | 3,516 | 2,828 | 3,332 | 2,222 | 2,451 | 2,111 | 2,249 |
| EBITDA | - | - | - | - | - | - | - | - | - | - |
| EBIT | - | - | -988.4 | -706.2 | -461.8 | -236.1 | -357.1 | -218.2 | - | - |
| Operating Margin | - | - | -25.89% | -20.09% | -16.33% | -7.09% | -16.07% | -8.9% | - | - |
| Earnings before Tax (EBT) | - | - | - | -652.9 | - | - | -244.3 | -87.63 | - | - |
| Net income | - | - | - | - | - | - | -244.6 | -77.98 | - | - |
| Net margin | - | - | - | - | - | - | -11.01% | -3.18% | - | - |
| EPS | - | - | -0.8000 | -0.5900 | -0.3900 | -0.1700 | -0.2300 | -0.0700 | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 24/08/21 | 02/02/21 | 24/08/21 | 15/03/22 | 18/08/22 | 13/03/23 | 24/08/23 | 19/03/24 | - | - |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 5,445 | 9,816 | 3,065 | 3,701 | - | 2,394 | 2,634 | 3,083 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -637 | -1,175 | -1,492 | -845 | - | -262 | 28 | 212 |
| ROE (net income / shareholders' equity) | -7.39% | -7.44% | -10.3% | -4.41% | - | -1.64% | -0.08% | 0.72% |
| ROA (Net income/ Total Assets) | -5.93% | -6.13% | -8.44% | -3.47% | - | -1.72% | -0.29% | 0.15% |
| Assets 1 | 12,376 | 15,471 | 18,222 | 17,511 | - | 12,315 | 26.96 | 61,905 |
| Book Value Per Share 2 | 9.040 | 13.80 | 12.30 | 12.00 | - | 11.70 | 11.60 | 12.00 |
| Cash Flow per Share 2 | -0.5000 | -1.070 | -1.270 | -0.7500 | - | 0.0900 | 0.2500 | 0.4800 |
| Capex 1 | 133 | 73.2 | 89.2 | 34.4 | - | 55.4 | 59.8 | 66.3 |
| Capex / Sales | 2.63% | 1.07% | 1.22% | 0.56% | - | 1% | 0.93% | 1% |
| Announcement Date | 11/02/20 | 02/02/21 | 15/03/22 | 13/03/23 | 19/03/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
11.22
CNY
Average target price
15.79
CNY
Spread / Average Target
+40.78%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +18.92% | 81.04B | |
| -29.48% | 68.93B | |
| +9.65% | 29.59B | |
| -0.14% | 17.24B | |
| -9.30% | 16.99B | |
| +0.20% | 15.12B | |
| +5.25% | 13.09B | |
| +68.96% | 12B | |
| -2.88% | 11.94B |
- Stock Market
- Equities
- 1833 Stock
- PIAHY Stock
- Financials Ping An Healthcare and Technology Company Limited